Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause (IPG738)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 21 September 2022
Transvaginal laser therapy for urogenital atrophy (IPG697)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 May 2021
Menopause: diagnosis and management (NG23)Product type:GuidanceProgramme:NICE guidelineLast updated: 5 December 2019Published: 12 November 2015
Menopause: diagnosis and managementStatus:In developmentProgramme:NICE guidelineExpected publication date: TBC
Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Women’s and reproductive health guidelinesStatus:In developmentProgramme:NICE HubExpected publication date: TBC
Elinzanetant for treating vasomotor symptoms associated with menopause TS ID 11917Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC